↓ Skip to main content

Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease

Overview of attention for article published in Frontiers in endocrinology, January 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
4 X users

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease
Published in
Frontiers in endocrinology, January 2023
DOI 10.3389/fendo.2022.1046392
Pubmed ID
Authors

Teodora V. Grigore, Malou Zuidscherwoude, Anna Witasp, Peter Barany, Annika Wernerson, Annette Bruchfeld, Hong Xu, Hannes Olauson, Joost Hoenderop

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 33%
Researcher 1 33%
Unknown 1 33%
Readers by discipline Count As %
Veterinary Science and Veterinary Medicine 2 67%
Unknown 1 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2023.
All research outputs
#14,927,037
of 26,414,132 outputs
Outputs from Frontiers in endocrinology
#2,972
of 13,537 outputs
Outputs of similar age
#187,527
of 492,783 outputs
Outputs of similar age from Frontiers in endocrinology
#179
of 1,004 outputs
Altmetric has tracked 26,414,132 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,537 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 492,783 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 1,004 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.